Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 21, 2017
IGFBP, a novel target of lung cancer?Qiongge Hu, Yong Zhou, Kejing Ying, et al.
Molecular Biology Reports|December 14, 2011
Lack of association between MDR1 C3435T polymorphism and chemotherapy response in advanced breast cancer patients: evidence from current studiesGuodi Chen, Sheng Quan, Qiongge Hu, et al.
Oncology Reports|January 19, 2008
Epidermal growth factor receptor and human epidermal growth receptor 2 expression in parotid mucoepidermoid carcinoma: possible implications for targeted therapyJinbiao Shang, Yongjie Shui, Liming Sheng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 9, 2020
Molecular hydrogen: A potential radioprotective agentQiongge Hu, Yunxiang Zhou, Shijie Wu, et al.
Annals of Surgical Oncology|January 4, 2008
EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastasesQichun Wei, Liming Sheng, Yongjie Shui, et al.
Oncology Research and Treatment|February 24, 2017
Long-Term Relief of Cerebral Radiation Necrosis Treated with Low-Dose Bevacizumab - a Report of 2 CasesQiongge Hu, Juan Zhao, Jing Xu, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 26, 2010
Comparison of the epidermal growth factor receptor protein expression between primary non-small cell lung cancer and paired lymph node metastases: implications for targeted nuclide radiotherapyChuangzhou Rao, Qiongge Hu, Jianhua Ma, et al.
Oncology Letters|July 12, 2017
Dynamic MRI follow-up of radiation encephalopathy in the temporal lobe following nasopharyngeal carcinoma radiotherapyXiaofeng Zhou, Xiaofang Liao, Xiaoqiu Ren, et al.
Molecular and Clinical Oncology|July 24, 2014
Parametric contrast-enhanced ultrasound as an early predictor of radiation-based therapeutic response for lymph node metastases of nasopharyngeal carcinomaZhimin Ye, Pintong Huang, Xiaofeng Zhou, et al.
Journal of Neuro-Oncology|October 17, 2023
Improved survival outcome with not-delayed radiotherapy and immediate PD-1/PD-L1 inhibitor for non-small-cell lung cancer patients with brain metastasesYaner Yu, Haiyan Chen, Zhifeng Tian, et al.
Pageof 2